HEADER RECOMBINATION 22-NOV-22 8BR9 TITLE STAPLED PEPTIDE SP24 IN COMPLEX WITH HUMANISED RADA MUTANT HUMRADA22 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA REPAIR AND RECOMBINATION PROTEIN RADA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HUMANISED RADA MUTANT HUMRADA22; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: FANCONI ANEMIA GROUP D1 PROTEIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS FURIOSUS; SOURCE 3 ORGANISM_TAXID: 2261; SOURCE 4 GENE: RADA, PF1926; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 GENE: BRCA2, FACD, FANCD1; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS STAPLED PEPTIDE, RAD51, BRCA2, BRC REPEAT, RECOMBINATION EXPDTA X-RAY DIFFRACTION AUTHOR T.PANTELEJEVS,M.HYVONEN REVDAT 3 07-FEB-24 8BR9 1 REMARK REVDAT 2 27-DEC-23 8BR9 1 JRNL REVDAT 1 08-MAR-23 8BR9 0 JRNL AUTH T.PANTELEJEVS,P.ZUAZUA-VILLAR,O.KOCZY,A.J.COUNSELL, JRNL AUTH 2 S.J.WALSH,N.S.ROBERTSON,D.R.SPRING,J.A.DOWNS,M.HYVONEN JRNL TITL A RECOMBINANT APPROACH FOR STAPLED PEPTIDE DISCOVERY YIELDS JRNL TITL 2 INHIBITORS OF THE RAD51 RECOMBINASE. JRNL REF CHEM SCI V. 14 13915 2023 JRNL REFN ISSN 2041-6520 JRNL PMID 38075664 JRNL DOI 10.1039/D3SC03331G REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.PANTELEJEVS,P.ZUAZUA-VILLAR,O.KOCZY,A.COUNSELL,S.J.WALSH, REMARK 1 AUTH 2 N.S.ROBERTSON,D.R.SPRING,J.DOWNS,M.HYVONEN REMARK 1 TITL A RECOMBINANT APPROACH FOR STAPLED PEPTIDE DISCOVERY YIELDS REMARK 1 TITL 2 INHIBITORS OF THE RAD51 RECOMBINASE REMARK 1 REF BIORXIV 2023 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2023.02.24.529929 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 29277 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1444 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5300 - 3.5000 0.99 3123 140 0.2121 0.2393 REMARK 3 2 3.5000 - 2.7800 0.99 2936 163 0.2479 0.2784 REMARK 3 3 2.7800 - 2.4300 0.99 2900 141 0.2675 0.3030 REMARK 3 4 2.4300 - 2.2100 0.98 2873 166 0.2755 0.2935 REMARK 3 5 2.2100 - 2.0500 0.98 2832 146 0.2971 0.3260 REMARK 3 6 2.0500 - 1.9300 0.98 2830 137 0.2937 0.3520 REMARK 3 7 1.9300 - 1.8300 0.98 2838 125 0.3734 0.3751 REMARK 3 8 1.8300 - 1.7500 0.98 2792 147 0.4580 0.5079 REMARK 3 9 1.7500 - 1.6900 0.96 2729 163 0.4738 0.4814 REMARK 3 10 1.6900 - 1.6300 0.69 1980 116 0.5417 0.5155 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.321 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 41.915 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 1925 REMARK 3 ANGLE : 1.604 2592 REMARK 3 CHIRALITY : 0.100 290 REMARK 3 PLANARITY : 0.006 341 REMARK 3 DIHEDRAL : 15.154 727 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|* B|*} REMARK 3 ORIGIN FOR THE GROUP (A): 19.2704 -26.3070 1.8341 REMARK 3 T TENSOR REMARK 3 T11: 0.4262 T22: 0.3085 REMARK 3 T33: 0.2542 T12: -0.0489 REMARK 3 T13: -0.0257 T23: 0.0142 REMARK 3 L TENSOR REMARK 3 L11: 3.0811 L22: 2.0939 REMARK 3 L33: 6.0761 L12: 0.7558 REMARK 3 L13: 0.3448 L23: -0.8227 REMARK 3 S TENSOR REMARK 3 S11: -0.1804 S12: -0.1396 S13: -0.0459 REMARK 3 S21: -0.0172 S22: -0.0029 S23: -0.0007 REMARK 3 S31: -0.2063 S32: 0.1516 S33: 0.1798 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BR9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292126785. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30303 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 70.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6HQU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA 3 CIT 4.2 PH (BUFFER) 20 %W/V REMARK 280 PEG 1K (PRECIPITANT) 0.2 M LI 2 SO4 (SALT), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 70.23200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.32100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.23200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 19.32100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 521 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 107 REMARK 465 ALA A 108 REMARK 465 THR A 109 REMARK 465 VAL A 297 REMARK 465 GLN A 298 REMARK 465 ALA A 299 REMARK 465 ASN A 300 REMARK 465 GLY A 301 REMARK 465 GLY A 302 REMARK 465 HIS A 303 REMARK 465 ILE A 304 REMARK 465 LEU A 305 REMARK 465 ALA A 306 REMARK 465 HIS A 307 REMARK 465 SER A 308 REMARK 465 ALA A 309 REMARK 465 GLY A 318 REMARK 465 LYS A 319 REMARK 465 GLY A 320 REMARK 465 ILE B 2045 REMARK 465 GLU B 2046 REMARK 465 ASN B 2047 REMARK 465 ILE B 2048 REMARK 465 SER B 2049 REMARK 465 VAL B 2050 REMARK 465 ASN B 2051 REMARK 465 SER B 2052 REMARK 465 SER B 2053 REMARK 465 ALA B 2054 REMARK 465 PHE B 2055 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 322 CG CD CE NZ REMARK 470 ASP B1243 CB CG OD1 OD2 DBREF 8BR9 A 107 349 UNP O74036 RADA_PYRFU 107 349 DBREF 8BR9 B 1226 2064 UNP P51587 BRCA2_HUMAN 1226 1263 SEQADV 8BR9 MET A 107 UNP O74036 ARG 107 ENGINEERED MUTATION SEQADV 8BR9 ALA A 168 UNP O74036 VAL 168 ENGINEERED MUTATION SEQADV 8BR9 MET A 169 UNP O74036 ILE 169 ENGINEERED MUTATION SEQADV 8BR9 TYR A 170 UNP O74036 TRP 170 ENGINEERED MUTATION SEQADV 8BR9 LEU A 182 UNP O74036 ILE 182 ENGINEERED MUTATION SEQADV 8BR9 ASP A 198 UNP O74036 LYS 198 ENGINEERED MUTATION SEQADV 8BR9 ASN A 199 UNP O74036 HIS 199 ENGINEERED MUTATION SEQADV 8BR9 VAL A 200 UNP O74036 ILE 200 ENGINEERED MUTATION SEQADV 8BR9 ALA A 201 UNP O74036 TYR 201 ENGINEERED MUTATION SEQADV 8BR9 TYR A 202 UNP O74036 VAL 202 ENGINEERED MUTATION SEQADV 8BR9 GLN A 213 UNP O74036 LEU 213 ENGINEERED MUTATION SEQADV 8BR9 LEU A 215 UNP O74036 VAL 215 ENGINEERED MUTATION SEQADV 8BR9 TYR A 216 UNP O74036 GLN 216 ENGINEERED MUTATION SEQADV 8BR9 SER A 219 UNP O74036 GLU 219 ENGINEERED MUTATION SEQADV 8BR9 ALA A 220 UNP O74036 ASP 220 ENGINEERED MUTATION SEQADV 8BR9 MET A 221 UNP O74036 LYS 221 ENGINEERED MUTATION SEQADV 8BR9 MET A 222 UNP O74036 ILE 222 ENGINEERED MUTATION SEQADV 8BR9 VAL A 223 UNP O74036 LYS 223 ENGINEERED MUTATION SEQADV 8BR9 SER A 225 UNP O74036 LEU 225 ENGINEERED MUTATION SEQADV 8BR9 TYR A 232 UNP O74036 VAL 232 ENGINEERED MUTATION SEQADV 8BR9 ARG A 263 UNP O74036 LYS 263 ENGINEERED MUTATION SEQADV 8BR9 PHE A 264 UNP O74036 HIS 264 ENGINEERED MUTATION SEQADV 8BR9 ARG A 266 UNP O74036 ALA 266 ENGINEERED MUTATION SEQADV 8BR9 MET A 267 UNP O74036 ASP 267 ENGINEERED MUTATION SEQADV 8BR9 GLU A 274 UNP O74036 LEU 274 ENGINEERED MUTATION SEQADV 8BR9 PHE A 275 UNP O74036 TYR 275 ENGINEERED MUTATION SEQADV 8BR9 ASN A 300 UNP O74036 ARG 288 ENGINEERED MUTATION SEQADV 8BR9 A UNP O74036 PRO 289 DELETION SEQADV 8BR9 A UNP O74036 ASP 290 DELETION SEQADV 8BR9 A UNP O74036 ALA 291 DELETION SEQADV 8BR9 A UNP O74036 PHE 292 DELETION SEQADV 8BR9 A UNP O74036 PHE 293 DELETION SEQADV 8BR9 A UNP O74036 GLY 294 DELETION SEQADV 8BR9 A UNP O74036 ASP 295 DELETION SEQADV 8BR9 A UNP O74036 PRO 296 DELETION SEQADV 8BR9 A UNP O74036 THR 297 DELETION SEQADV 8BR9 A UNP O74036 ARG 298 DELETION SEQADV 8BR9 A UNP O74036 PRO 299 DELETION SEQADV 8BR9 A UNP O74036 ILE 300 DELETION SEQADV 8BR9 CYS B 1231 UNP P51587 THR 1231 ENGINEERED MUTATION SEQADV 8BR9 GLN B 1232 UNP P51587 GLU 1232 ENGINEERED MUTATION SEQADV 8BR9 CYS B 1238 UNP P51587 VAL 1238 ENGINEERED MUTATION SEQADV 8BR9 VAL B 2050 UNP P51587 GLU 1249 ENGINEERED MUTATION SEQADV 8BR9 ASN B 2051 UNP P51587 GLU 1250 ENGINEERED MUTATION SEQADV 8BR9 SER B 2052 UNP P51587 THR 1251 ENGINEERED MUTATION SEQADV 8BR9 PHE B 2055 UNP P51587 GLU 1254 ENGINEERED MUTATION SEQADV 8BR9 SER B 2056 UNP P51587 VAL 1255 ENGINEERED MUTATION SEQADV 8BR9 GLY B 2057 UNP P51587 HIS 1256 ENGINEERED MUTATION SEQADV 8BR9 PHE B 2058 UNP P51587 PRO 1257 ENGINEERED MUTATION SEQADV 8BR9 SER B 2059 UNP P51587 ILE 1258 ENGINEERED MUTATION SEQADV 8BR9 THR B 2060 UNP P51587 SER 1259 ENGINEERED MUTATION SEQADV 8BR9 ALA B 2061 UNP P51587 LEU 1260 ENGINEERED MUTATION SEQADV 8BR9 GLY B 2063 UNP P51587 SER 1262 ENGINEERED MUTATION SEQADV 8BR9 LYS B 2064 UNP P51587 SER 1263 ENGINEERED MUTATION SEQRES 1 A 231 MET ALA THR ILE GLY ARG ILE SER THR GLY SER LYS SER SEQRES 2 A 231 LEU ASP LYS LEU LEU GLY GLY GLY ILE GLU THR GLN ALA SEQRES 3 A 231 ILE THR GLU VAL PHE GLY GLU PHE GLY SER GLY LYS THR SEQRES 4 A 231 GLN LEU ALA HIS THR LEU ALA VAL MET VAL GLN LEU PRO SEQRES 5 A 231 PRO GLU GLU GLY GLY LEU ASN GLY SER ALA MET TYR ILE SEQRES 6 A 231 ASP THR GLU ASN THR PHE ARG PRO GLU ARG LEU ARG GLU SEQRES 7 A 231 ILE ALA GLN ASN ARG GLY LEU ASP PRO ASP GLU VAL LEU SEQRES 8 A 231 ASP ASN VAL ALA TYR ALA ARG ALA PHE ASN SER ASN HIS SEQRES 9 A 231 GLN MET GLN LEU LEU TYR GLN ALA SER ALA MET MET VAL SEQRES 10 A 231 GLU SER LEU ASN THR ASP ARG PRO TYR LYS LEU LEU ILE SEQRES 11 A 231 VAL ASP SER LEU THR SER HIS PHE ARG SER GLU TYR ILE SEQRES 12 A 231 GLY ARG GLY ALA LEU ALA GLU ARG GLN GLN LYS LEU ALA SEQRES 13 A 231 ARG PHE LEU ARG MET LEU HIS ARG LEU ALA ASN GLU PHE SEQRES 14 A 231 ASP ILE ALA VAL PHE VAL THR ASN GLN VAL GLN ALA ASN SEQRES 15 A 231 GLY GLY HIS ILE LEU ALA HIS SER ALA THR LEU ARG VAL SEQRES 16 A 231 TYR LEU ARG LYS GLY LYS GLY GLY LYS ARG ILE ALA ARG SEQRES 17 A 231 LEU ILE ASP ALA PRO HIS LEU PRO GLU GLY GLU ALA VAL SEQRES 18 A 231 PHE SER ILE THR GLU LYS GLY ILE GLU ASP SEQRES 1 B 38 LYS LEU ASN VAL SER CYS GLN ALA LEU GLN LYS ALA CYS SEQRES 2 B 38 LYS LEU PHE SER ASP ILE GLU ASN ILE SER VAL ASN SER SEQRES 3 B 38 SER ALA PHE SER GLY PHE SER THR ALA SER GLY LYS HET ADP A 401 39 HET RF6 B2101 11 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM RF6 4,6-DIETHYLPYRIMIDIN-2-AMINE HETSYN RF6 4,6-BIS(ETHENYL)PYRIMIDIN-2-AMINE (PRECURSOR); 4,6- HETSYN 2 RF6 DIVINYLPYRIMIDIN-2-AMINE (PRECURSOR); PEPTIDE STAPLE FORMUL 3 ADP C10 H15 N5 O10 P2 FORMUL 4 RF6 C8 H13 N3 FORMUL 5 HOH *82(H2 O) HELIX 1 AA1 SER A 117 LEU A 124 1 8 HELIX 2 AA2 GLY A 143 VAL A 155 1 13 HELIX 3 AA3 GLN A 156 LEU A 157 5 2 HELIX 4 AA4 PRO A 158 GLY A 162 5 5 HELIX 5 AA5 ARG A 178 ARG A 189 1 12 HELIX 6 AA6 ASP A 192 ASN A 199 1 8 HELIX 7 AA7 ASN A 207 LEU A 226 1 20 HELIX 8 AA8 THR A 241 TYR A 248 1 8 HELIX 9 AA9 GLY A 250 GLY A 252 5 3 HELIX 10 AB1 ALA A 253 ASP A 276 1 24 HELIX 11 AB2 SER B 1230 PHE B 1241 1 12 SHEET 1 AA1 2 ARG A 112 ILE A 113 0 SHEET 2 AA1 2 ILE A 128 GLU A 129 -1 O ILE A 128 N ILE A 113 SHEET 1 AA210 GLY A 346 GLU A 348 0 SHEET 2 AA210 GLU A 337 THR A 343 -1 N THR A 343 O GLY A 346 SHEET 3 AA210 ARG A 323 ILE A 328 -1 N ALA A 325 O ALA A 338 SHEET 4 AA210 LEU A 311 ARG A 316 -1 N ARG A 316 O ILE A 324 SHEET 5 AA210 ALA A 132 PHE A 137 1 N GLU A 135 O LEU A 311 SHEET 6 AA210 ALA A 278 ASN A 283 1 O VAL A 279 N THR A 134 SHEET 7 AA210 TYR A 232 ASP A 238 1 N LYS A 233 O ALA A 278 SHEET 8 AA210 SER A 167 ASP A 172 1 N ILE A 171 O ILE A 236 SHEET 9 AA210 VAL A 200 ARG A 204 1 O ALA A 201 N ALA A 168 SHEET 10 AA210 SER B2059 THR B2060 -1 O SER B2059 N TYR A 202 LINK N LYS B1226 C LYS B2064 1555 1555 1.33 LINK SG CYS B1231 C7 RF6 B2101 1555 1555 1.88 LINK SG CYS B1238 C RF6 B2101 1555 1555 1.85 CRYST1 140.464 38.642 43.528 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007119 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025879 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022974 0.00000